Audientes accelerates preparations for US market entry after OTC market news

Hearing device manufacturer Audientes sees a golden opportunity on the US hearing aid market, and with the release of Tuesday's FDA proposal for the guidelines of the upcoming over-the-counter sales channel, the company has taken its plans for hearing device "Ven" up a gear.

Steen Thygesen, CEO at Audientes | Photo: Audientes / PR

The US, which is indisputably the world's biggest single market for hearing aids, is changing its laws regarding the sales of non-prescription devices, with cheaper products being able to hit shelves in September of next year at the latest.

One of the companies offering cheaper hearing solutions is Audientes, which is based in Denmark and went public on the Copenhagen stock exchange in September last year, and is currently going all in to win the FDA's approval to market its low cost hearing devices to Americans affected by hearing loss.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs